ATE214372T1 - Verfahren zur herstellung von anti-malaria arzneimittel - Google Patents
Verfahren zur herstellung von anti-malaria arzneimittelInfo
- Publication number
- ATE214372T1 ATE214372T1 AT96934646T AT96934646T ATE214372T1 AT E214372 T1 ATE214372 T1 AT E214372T1 AT 96934646 T AT96934646 T AT 96934646T AT 96934646 T AT96934646 T AT 96934646T AT E214372 T1 ATE214372 T1 AT E214372T1
- Authority
- AT
- Austria
- Prior art keywords
- producing anti
- malaria drugs
- malaria
- drugs
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9521004.3A GB9521004D0 (en) | 1995-10-13 | 1995-10-13 | Process |
| PCT/EP1996/004433 WO1997013753A1 (en) | 1995-10-13 | 1996-10-11 | Process for the preparation of anti-malarial drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE214372T1 true ATE214372T1 (de) | 2002-03-15 |
Family
ID=10782264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96934646T ATE214372T1 (de) | 1995-10-13 | 1996-10-11 | Verfahren zur herstellung von anti-malaria arzneimittel |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6479660B1 (de) |
| EP (1) | EP0871616B1 (de) |
| JP (1) | JP4083803B2 (de) |
| KR (1) | KR100453256B1 (de) |
| CN (1) | CN1147475C (de) |
| AR (1) | AR004015A1 (de) |
| AT (1) | ATE214372T1 (de) |
| AU (1) | AU709333B2 (de) |
| BR (1) | BR9611010A (de) |
| CA (1) | CA2231633C (de) |
| CZ (1) | CZ290380B6 (de) |
| DE (1) | DE69619863T2 (de) |
| DK (1) | DK0871616T3 (de) |
| ES (1) | ES2170874T3 (de) |
| GB (1) | GB9521004D0 (de) |
| HK (1) | HK1016180A1 (de) |
| HU (1) | HUP9900739A3 (de) |
| IL (1) | IL124060A (de) |
| NO (1) | NO313285B1 (de) |
| NZ (1) | NZ320209A (de) |
| PL (1) | PL186055B1 (de) |
| PT (1) | PT871616E (de) |
| SA (1) | SA97170574B1 (de) |
| SI (1) | SI0871616T1 (de) |
| TR (1) | TR199800637T2 (de) |
| TW (1) | TW450950B (de) |
| WO (1) | WO1997013753A1 (de) |
| ZA (1) | ZA968550B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08276712A (ja) * | 1995-04-05 | 1996-10-22 | Masao Tsuji | チュ−ブレススパイクタイヤ |
| GB0210150D0 (en) * | 2002-05-03 | 2002-06-12 | Smithkline Beecham Plc | Process |
| WO2007032016A1 (en) * | 2005-09-12 | 2007-03-22 | Council Of Scientific And Industrial Research | An antimalarial baylis-hillman adducts and a process for the preparation thereof |
| WO2007127930A2 (en) * | 2006-04-28 | 2007-11-08 | Kansas State University Research Foundation | Compounds affecting gap junction activity |
| GB0620005D0 (en) | 2006-10-10 | 2006-11-22 | Glaxo Group Ltd | Compounds |
| US20090076072A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched tafenoquine |
| ES2453206B1 (es) | 2013-09-25 | 2015-01-12 | Thyssenkrupp Elevator Innovation Center, S.A. | Sistema de tracción para un sistema de transporte |
| CN113248431A (zh) * | 2021-05-21 | 2021-08-13 | 重庆医药高等专科学校 | 一种磷酸伯氨喹的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431807A (en) * | 1980-06-12 | 1984-02-14 | The United States Of America As Represented By The Secretary Of The Army | 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines |
| US4617394A (en) | 1985-10-15 | 1986-10-14 | The United States Of America As Represented By The Secretary Of The Army | 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines |
-
1995
- 1995-10-13 GB GBGB9521004.3A patent/GB9521004D0/en active Pending
-
1996
- 1996-10-10 ZA ZA9608550A patent/ZA968550B/xx unknown
- 1996-10-11 AU AU72910/96A patent/AU709333B2/en not_active Ceased
- 1996-10-11 KR KR10-1998-0702696A patent/KR100453256B1/ko not_active IP Right Cessation
- 1996-10-11 US US09/051,571 patent/US6479660B1/en not_active Expired - Fee Related
- 1996-10-11 EP EP96934646A patent/EP0871616B1/de not_active Expired - Lifetime
- 1996-10-11 CA CA002231633A patent/CA2231633C/en not_active Expired - Fee Related
- 1996-10-11 PL PL96326194A patent/PL186055B1/pl not_active IP Right Cessation
- 1996-10-11 IL IL12406096A patent/IL124060A/xx not_active IP Right Cessation
- 1996-10-11 HU HU9900739A patent/HUP9900739A3/hu unknown
- 1996-10-11 WO PCT/EP1996/004433 patent/WO1997013753A1/en active IP Right Grant
- 1996-10-11 CZ CZ19981103A patent/CZ290380B6/cs not_active IP Right Cessation
- 1996-10-11 DE DE69619863T patent/DE69619863T2/de not_active Expired - Lifetime
- 1996-10-11 SI SI9630461T patent/SI0871616T1/xx unknown
- 1996-10-11 ES ES96934646T patent/ES2170874T3/es not_active Expired - Lifetime
- 1996-10-11 JP JP51471997A patent/JP4083803B2/ja not_active Expired - Fee Related
- 1996-10-11 CN CNB961975644A patent/CN1147475C/zh not_active Expired - Fee Related
- 1996-10-11 TR TR1998/00637T patent/TR199800637T2/xx unknown
- 1996-10-11 AT AT96934646T patent/ATE214372T1/de not_active IP Right Cessation
- 1996-10-11 AR ARP960104723A patent/AR004015A1/es active IP Right Grant
- 1996-10-11 DK DK96934646T patent/DK0871616T3/da active
- 1996-10-11 PT PT96934646T patent/PT871616E/pt unknown
- 1996-10-11 NZ NZ320209A patent/NZ320209A/xx not_active IP Right Cessation
- 1996-10-11 BR BR9611010A patent/BR9611010A/pt not_active Application Discontinuation
- 1996-10-14 TW TW085112489A patent/TW450950B/zh active
-
1997
- 1997-01-20 SA SA97170574A patent/SA97170574B1/ar unknown
-
1998
- 1998-04-03 NO NO19981537A patent/NO313285B1/no not_active IP Right Cessation
-
1999
- 1999-04-07 HK HK99101378A patent/HK1016180A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE243211T1 (de) | Verfahren zur herstellung von dihalogenazolopyrimidinen | |
| DE59604922D1 (de) | Verfahren zur herstellung von polyalkoholen | |
| DE69604277D1 (de) | Verfahren zur herstellung von nootkaton | |
| DE59609854D1 (de) | Verfahren zur herstellung von verkappten polyarylenethern | |
| ATE187727T1 (de) | Verfahren zur herstellung von imidazo- benzodiazepin-derivaten | |
| ATE229021T1 (de) | Verfahren zur herstellung von imidazochinazolinon-derivaten | |
| ATE267812T1 (de) | Verfahren zur herstellung von n-substituierten 3- hydroxypyrazolen | |
| DE59601604D1 (de) | Verfahren zur herstellung von n-aryl- und n-hetarylhydroxylaminen | |
| DE69628203D1 (de) | Verfahren zur herstellung von phenylimidazolin-derivaten | |
| ATE303134T1 (de) | Verfahren zur herstellung von flavano-lignan- zubereitungen | |
| ATE309230T1 (de) | Verfahren zur herstellung von 2- chlorthiazolderivaten | |
| DE69614571D1 (de) | Verfahren zur herstellung von lovastatin | |
| DE59601895D1 (de) | Verfahren zur herstellung von butyrolactonen | |
| DE69616322D1 (de) | Verfahren zur herstellung von 3-isochromanonen | |
| ATE207900T1 (de) | Verfahren zur herstellung von ropivacainehydrochlorid-monohydrat | |
| DE69601993T2 (de) | Verfahren zur herstellung von doxorubicin | |
| ATE214372T1 (de) | Verfahren zur herstellung von anti-malaria arzneimittel | |
| DE69625466T2 (de) | Verfahren zur herstellung von polyethylennaphathalat | |
| DE69615836D1 (de) | Verfahren zur herstellung von boroxyd | |
| DE59604459D1 (de) | Verfahren zur herstellung von carbonsäurederivaten | |
| ATE215067T1 (de) | Verfahren zur herstellung von pestiziden | |
| ATE198325T1 (de) | Verfahren zur herstellung von dioxoazabiclohexanderivaten | |
| DE69617643D1 (de) | Verfahren zur herstellung von difluormethan und difluorchlormethan | |
| DE69609499T2 (de) | Verfahren zur herstellung von streptograminen | |
| DE69608811T2 (de) | Verfahren zur herstellung von heptafluorpropan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0871616 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |